Das Klinikum Nürnberg ist eines der größten kommunalen Krankenhäuser Europas und ein Krankenhaus der Maximalversorgung. Mit seinen 6.976 Mitarbeitern versorgt es im Jahr knapp über 100.000 stationäre sowie ca. 170.000 ambulante Patienten. Am Centrum für Pflegeberufe lernen rund 440 Auszubildende.

During the past decade, Klinikum Nürnberg Nord conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 7 clinical trials were completed, i.e. on average, 30.4% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 4 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Nürnberg Nord" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 5 trials, followed by "Goethe University" with 5 trials sponsored, "German CLL Study Group" with 4 trials sponsored, "Technische Universität Dresden" with 4 trials sponsored and "DKMS gemeinnützige GmbH" with 4 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Nürnberg Nord" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "AF Schimetta GMbH" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "CHUGAI sanofi-aventis" with 1 trials as a collaborator and "CRI-The Clinical Research Institute GmbH" with 1 trials as a collaborator. Other collaborators include 32 different institutions and companies that were collaborators in the rest 42 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Nürnberg Nord" are "Acute Myeloid Leukemia" (4 trials), "Chronic Lymphocytic Leukemia" (4 trials), "Leukemia" (3 trials), "Lymphoma" (3 trials) and "AML" (2 trials). Many other conditions were trialed in "Klinikum Nürnberg Nord" in a lesser frequency.

Most popular intervention types in "Klinikum Nürnberg Nord" are "Drug" (49 trials), "Biological" (11 trials), "Procedure" (9 trials), "Radiation" (5 trials) and "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "filgrastim" (7 trials), "cyclophosphamide" (6 trials), "cisplatin" (5 trials), "etoposide" (5 trials) and "peripheral blood stem cell transplantation" (5 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Nürnberg Nord" are 51 trials for "All" genders, 4 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Nürnberg Nord". undefined are not yet recruiting, 13 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in Klinikum Nürnberg Nord, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Nürnberg Nord, 3 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".